Last reviewed · How we verify
FPNS
At a glance
| Generic name | FPNS |
|---|---|
| Also known as | fluticasone propionate, fluticasone furoate |
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea (PHASE2)
- A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis (PHASE4)
- Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS (PHASE4)
- Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS (PHASE4)
- PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |